Cargando…

Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic Review

Purpose. This paper aims to review the morphological and functional characteristics of patients affected by familial amyloid polyneuropathy (FAP), with greater focus on type I and its progression after liver transplantation. We also analyse therapeutic options for the ophthalmic manifestations. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martins, A. C., Rosa, A. M., Costa, E., Tavares, C., Quadrado, M. J., Murta, J. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628973/ https://www.ncbi.nlm.nih.gov/pubmed/26558262 http://dx.doi.org/10.1155/2015/282405

Ejemplares similares

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
por: Rousseau, Antoine, et al.
Publicado: (2015)

Familial Amyloid Polyneuropathy Misdiagnosed as Systemic Sclerosis
por: Pereira, Márcia Agostinho, et al.
Publicado: (2022)

Inflammatory profiling of patients with familial amyloid polyneuropathy
por: Azevedo, Estefania P., et al.
Publicado: (2019)

Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal
por: Inês, Mónica, et al.
Publicado: (2015)

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria
por: Sarafov, Stayko, et al.
Publicado: (2015)

Psychopathological dimensions in familial amyloid polyneuropathy patients
por: Lopes, Alice, et al.
Publicado: (2015)

The rehabilitation in the management of Transthyretin Familial Amyloid Polyneuropathy
por: Morier, Agnès, et al.
Publicado: (2015)

Preimplantation genetic testing for familial amyloid polyneuropathy
por: Sousa, Mário
Publicado: (2022)

Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells
por: Niemietz, Christoph J., et al.
Publicado: (2016)

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
por: Bolte, Fabian J., et al.
Publicado: (2020)

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H., et al.
Publicado: (2018)

Transthyretin familial amyloid polyneuropathy impact on health-related quality of life
por: Inês, Mónica, et al.
Publicado: (2015)

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
por: Coelho, Teresa, et al.
Publicado: (2013)

Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy
por: Collins, Michael, et al.
Publicado: (2018)

Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H.‐J., et al.
Publicado: (2016)

“Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy
por: Conceição, Isabel, et al.
Publicado: (2016)

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Du, Kang, et al.
Publicado: (2021)

Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
por: Coelho, Teresa, et al.
Publicado: (2015)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
por: Koike, Haruki, et al.
Publicado: (2015)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy
por: Lopes, Alice, et al.
Publicado: (2017)

Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France
por: Mariani, Louise‐Laure, et al.
Publicado: (2015)

The Temporal Profiles of Changes in Nerve Excitability Indices in Familial Amyloid Polyneuropathy
por: Lai, Hsing-Jung, et al.
Publicado: (2015)

Familial amyloid polyneuropathy in Portugal: New genes modulating age‐at‐onset
por: Santos, Diana, et al.
Publicado: (2016)

Transthyretin familial amyloid polyneuropathy (TTR‐FAP): Parameters for early diagnosis
por: Escolano‐Lozano, Fabiola, et al.
Publicado: (2017)

Clinical and genetic features of transthyretin-related familial amyloid polyneuropathy in China
por: Liu, Lei, et al.
Publicado: (2020)

Transthyretin interacts with actin regulators in a Drosophila model of familial amyloid polyneuropathy
por: I. Oliveira da Silva, Marina, et al.
Publicado: (2020)

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy
por: Adams, David, et al.
Publicado: (2016)

Aqueous humor erythropoietin levels in open-angle glaucoma patients with and without TTR V30M familial amyloid polyneuropathy
por: Beirão, João M., et al.
Publicado: (2014)

Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis
por: Hund, Ernst
Publicado: (2012)

Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy
por: Warendorf, Janna K., et al.
Publicado: (2023)

A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin
Publicado: (1981)

Clinical, epidemiological, genetic, and electrophysiological characteristics of transthyretin familial amyloid polyneuropathies in Israel
por: Sadeh, Menachem, et al.
Publicado: (2015)

In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography
por: Kollmer, Jennifer, et al.
Publicado: (2015)

Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
por: Suenaga, Genki, et al.
Publicado: (2017)

Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer
por: Cotrina, Ellen Y., et al.
Publicado: (2020)

Vagus nerve ultrasound in transthyretin familial amyloid polyneuropathy: A pilot study
por: Du, Kang, et al.
Publicado: (2021)

Iatrogenic amyloid polyneuropathy after domino liver transplantation
por: Mnatsakanova, Diana, et al.
Publicado: (2017)

Ocular Manifestations in a Chinese Pedigree of Familial Amyloidotic Polyneuropathy Carrying the Transthyretin Mutation c.401A>G (p.Tyr134Cys)
por: Zhuang, Xiaonan, et al.
Publicado: (2022)

Optimizing the management of transthyretin familial amyloid polyneuropathy in Europe: early diagnosis and effective care
por: Adams, David
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jro9frsg4ksiqq07omg6p6a2s3